Emergen Research, a globally recognized provider of market research and consulting services, has recently released its latest comprehensive study on the global Nursing Robot Market. The report provides an in-depth assessment of market size, revenue growth, emerging trends, key growth drivers, restraints, technological developments, competitive dynamics, and regional opportunities shaping the nursing robotics industry through 2035.

The global Nursing Robot Market was valued at USD 1.28 Billion in 2025 and is projected to grow from USD 1.52 Billion in 2026 to USD 8.45 Billion by 2035, registering a CAGR of 21.0% during the forecast period from 2026 to 2035. North America accounted for the largest revenue share of 38.9% in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period.

The market is witnessing increasing adoption of robotics across hospitals, rehabilitation centers, nursing homes, and other care environments. Growing nursing labor shortages, rising demand for automated medication and supply delivery, increasing clinical acceptance of wearable rehabilitation robotics, and government-supported care-robot adoption in aging societies are creating new opportunities for nursing robot manufacturers and technology providers.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/220512

The Nursing Robot Market is increasingly becoming an important part of healthcare automation as hospitals seek technologies that can reduce repetitive workloads while allowing nurses and other healthcare professionals to spend more time on direct patient care. Mobile assistive and delivery robots are being deployed for medication transportation, laboratory sample movement, supply restocking, and other recurring logistics activities that traditionally require significant amounts of staff time.

Hospital reliance on manual staff for repetitive, non-clinical logistics activities is one of the major factors supporting market growth. A mobile delivery robot can independently move medications, laboratory samples, and medical supplies across hospital floors, allowing nursing staff to focus on patient-facing responsibilities. Diligent Robotics' Moxi platform has completed more than 1.25 million autonomous deliveries across more than 25 U.S. hospitals, demonstrating the increasing commercial adoption of mobile hospital robotics.

The acquisition activity among robotics companies is also influencing the competitive structure of the market. On 20 January 2026, Serve Robotics entered into an agreement to acquire Diligent Robotics, expanding its autonomous robotics platform from outdoor sidewalk delivery into indoor hospital environments. The development highlights the growing interest in combining established autonomy platforms with proven healthcare robotics deployments.

Clinical reimbursement support for wearable rehabilitation robotics is another important growth factor. Wearable robotic systems and powered exoskeletons are increasingly being used for stroke rehabilitation, neurological injury recovery, and mobility-related therapy. Myomo, which develops the MyoPro upper-limb orthosis, reported first-quarter 2025 revenue of USD 9.8 Million, representing significant year-over-year growth as more authorizations were converted into completed orders.

Government-backed adoption of care robots is also creating opportunities, particularly in countries experiencing rapid population aging. Japan has supported nursing-home care-robot adoption through government and prefectural subsidy programs, encouraging healthcare facilities to introduce robotics for care assistance, mobility support, and other operational activities.

At the same time, high capital expenditure requirements and inconsistent regulatory pathways remain important challenges. Hospitals and nursing facilities may hesitate to move from pilot projects to large-scale deployments when the upfront investment is high and the expected return on investment is difficult to establish. Semiconductor, battery, precision actuator, and other component costs can further influence the economics of robot production and deployment.

The market is also experiencing restructuring among early-stage robotics developers. Such developments demonstrate the difficulty smaller robotics companies can face when attempting to achieve sustainable scale in a relatively young market. These factors are expected to influence the pace of market expansion during the forecast period.

Odyss by Emergen Research

Odyss is Emergen Research's AI-powered data intelligence platform that provides strategy teams, investors, analysts, and business professionals with instant access to market datasets, reports, and structured industry intelligence.

Through the Odyss platform, users can explore more than 5,000 market reports, use AI-powered search capabilities, access exportable datasets, collaborate with teams, and analyze information across more than 50 industry verticals. The platform is designed to support faster market research and strategic decision-making by bringing structured market information into a single environment.

Explore Odyss Platform | Talk To An Analyst | View Pricing

Cost Effective Custom Report

competitive landscape:-

The global Nursing Robot Market is moderately fragmented, with established robotics developers, healthcare technology companies, medical-device manufacturers, and emerging robotics startups participating in the market. Companies are focusing on product development, strategic agreements, acquisitions, technology integration, and expansion into new healthcare environments to strengthen their market presence.

Some of the major companies operating in the global Nursing Robot Market include Serve Robotics Inc., CYBERDYNE, Inc., Diligent Robotics, Inc., Myomo, Inc., Lifeward Ltd., Aethon, Inc., Intuition Robotics Ltd., Panasonic Corporation, Relay Robotics, Inc., and Toyota Motor Corporation.

The competitive environment is being influenced by the increasing importance of autonomous navigation, AI-based decision-making, human-robot interaction, wearable robotics, and hospital workflow integration. Developers are increasingly using deployment data to improve robot performance and develop new generations of healthcare robotics platforms.

For example, Diligent Robotics unveiled Moxi 2.0 in October 2025, introducing a next-generation AI-native platform based on several years of real-world deployment data collected from hospital environments. The company has reported more than 1.25 million deliveries through its deployed Moxi robots, demonstrating the importance of real-world operating data in the development of healthcare robotics.

The acquisition agreement between Serve Robotics and Diligent Robotics further demonstrates the industry's movement toward consolidation and technology integration. Combining autonomy technology, software infrastructure, supply-chain capabilities, and established hospital deployments could allow robotics developers to expand into additional healthcare and indoor environments.

Market segmentation:-

The global Nursing Robot Market has been segmented based on product type, application, end user, and region.

Based on product type, the market is segmented into Mobile Assistive & Delivery Robots, Robotic Exoskeletons, Telepresence & Companion Robots, and Others. Mobile Assistive & Delivery Robots accounted for the largest market share of 42.6% in 2025.

Mobile assistive and delivery robots are increasingly being used to automate repetitive hospital logistics activities such as medication transportation, laboratory sample movement, and supply restocking. These systems generally operate autonomously across hospital corridors and elevators and use cameras, LiDAR, onboard computing, and AI-based navigation technologies.

The strong position of this segment is primarily associated with the direct labor-saving potential of mobile robots. Hospitals already allocate nursing and support staff to perform repetitive transportation tasks, creating a measurable operational cost against which robot deployment can be evaluated. This makes mobile delivery robots particularly attractive for hospitals seeking to address nursing labor shortages without increasing staff requirements.

The Robotic Exoskeletons segment is expected to register a rapid CAGR of 24.3% through 2035. Growing clinical acceptance of wearable rehabilitation devices and increasing reimbursement support are contributing to demand for robotic exoskeleton technologies. Unlike mobile delivery robots, exoskeletons directly interact with patients and are used to assist or restore specific body movements during rehabilitation and therapy.

CYBERDYNE has continued to develop and commercialize its Medical HAL technology, with reported demand across Japan, Europe, and Asia Pacific. The growing adoption of rehabilitation robotics is expected to support the expansion of this segment during the forecast period.

Based on application, the global Nursing Robot Market is segmented into Physical Assistance & Mobility Support, Medication & Supply Delivery, Rehabilitation & Physical Therapy, and Others. Medication & Supply Delivery accounted for the largest market share of 35.8% in 2025.

Medication and supply delivery represents one of the most established applications for nursing robots because hospitals perform large volumes of recurring transportation activities every day. Robots can transport medications, laboratory samples, and supplies between departments and patient floors, reducing the amount of time healthcare workers spend on non-clinical logistics.

Rehabilitation & Physical Therapy is expected to register a rapid CAGR of 23.1% through 2035. The growth of this segment is supported by increasing utilization of robotic systems for rehabilitation and the gradual development of reimbursement pathways for wearable robotic devices.

Based on end user, the global Nursing Robot Market is segmented into Hospitals & Clinics, Rehabilitation Centers, Nursing Homes & Long-Term Care Facilities, and Others. Hospitals & Clinics accounted for the largest market share of 58.4% in 2025.

Hospitals and clinics represent the largest end-user group because they have significant operational requirements, large patient populations, and increasing pressure to address nursing labor shortages. Many facilities initially deploy robots through pilot programs before expanding successful applications across multiple departments or hospital floors.

The Nursing Homes & Long-Term Care Facilities segment is expected to register a rapid CAGR of 22.7% through 2035. Aging populations and government-supported care-robot programs are expected to create additional opportunities for robotics in long-term care settings. Unlike acute-care hospitals, nursing homes may use robots for longer-term resident support, mobility assistance, monitoring, communication, and companion applications.

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/220512

The nursing robotics value chain extends from component and technology suppliers to robotics developers and institutional healthcare customers. Upstream suppliers provide components such as precision actuators, motors, lithium-ion battery systems, LiDAR and depth sensors, and onboard computing platforms. Robotics companies integrate these technologies into mobile or wearable platforms while developing the software and autonomy systems that differentiate their products.

Developers such as Diligent Robotics, CYBERDYNE, Myomo, and other robotics companies supply systems to hospitals, rehabilitation facilities, and nursing-care organizations. Because the market is still developing, many deployments involve direct agreements between robotics developers and institutional customers, with hardware, software updates, fleet management, and technical support frequently incorporated into the deployment relationship.

The regulatory environment also varies according to the type of nursing robot. Wearable and physically assistive systems that interact directly with patients may be regulated as medical devices, while robots used primarily for logistics and delivery may fall outside medical-device frameworks when they do not interact with patients or make clinical decisions.

In the United States, medical robotics technologies can be subject to FDA clearance requirements depending on their intended use. Cyberdyne's Medical HAL Lower Limb exoskeleton, for example, received FDA clearance under the 510(k) pathway. In contrast, mobile hospital logistics robots such as Moxi operate primarily as non-patient-facing transportation systems.

Government support is playing an important role in care-robot adoption outside the United States. Japan has supported nursing-home care-robot adoption through subsidy programs since 2015. Research published in Labour Economics in January 2025 found that nursing homes receiving subsidy-supported access to care robots experienced an increase in care-worker employment and improved staffing retention, highlighting the potential role of public policy in supporting healthcare robotics adoption.

The regional outlook also demonstrates significant differences in adoption patterns. North America accounted for 38.9% of global revenue in 2025, supported by a strong concentration of hospital systems, robotics developers, medical-device companies, and technology-focused healthcare organizations.

The United States represents the leading market within North America, supported by the presence of companies developing mobile delivery robots, wearable exoskeletons, and healthcare automation platforms. The region also benefits from established hospital technology infrastructure and a growing number of commercial robotics deployments.

Europe accounted for approximately 26.1% of the global market in 2025. The region is supported by rehabilitation robotics adoption, healthcare automation programs, and the presence of companies involved in wearable and assistive robotics.

Asia Pacific is expected to register the fastest growth, with the market projected to expand at a CAGR of 24.8% through 2035. Japan's long-standing government support for care robots, combined with rapidly aging populations across several countries in the region, is creating strong opportunities for market expansion. China and South Korea are also developing their healthcare robotics ecosystems, increasing the region's long-term growth potential.

Latin America is projected to register a CAGR of 15.6% through 2035. Adoption is currently concentrated in selected hospital systems, particularly in Brazil and Mexico, but expanding healthcare automation investments are expected to create additional opportunities.

The Middle East & Africa market is projected to grow at a CAGR of 14.2% through 2035. Saudi Arabia and the UAE are emerging as important markets because of increasing investments in healthcare infrastructure, hospital automation, and advanced medical technologies.

Recent Industry Developments

The Nursing Robot Market continues to experience significant developments involving acquisitions, new product launches, business restructuring, and expansion into new healthcare settings.

On 20 January 2026, Serve Robotics entered into an agreement to acquire Diligent Robotics, expanding its autonomous robotics capabilities into indoor healthcare environments. The transaction is expected to provide opportunities to integrate the companies' autonomy, artificial intelligence, technology infrastructure, and supply-chain capabilities.

On 28 October 2025, Diligent Robotics introduced Moxi 2.0, a next-generation AI-powered hospital robot developed using real-world deployment data. The platform was introduced after the company had accumulated more than 1.25 million deliveries across hospital environments.

On 5 May 2026, Ekso Bionics Holdings completed a reverse merger with Applied Digital Corporation's cloud-computing business. The combined company subsequently operated as ChronoScale Corporation, significantly changing the business structure of what had previously been a medical exoskeleton-focused company. The development illustrates the challenges faced by smaller robotics developers seeking sustainable scale.

Future Outlook

The future of the Nursing Robot Market is closely connected to the broader transformation of healthcare delivery and workforce management. Hospitals are increasingly evaluating robotics not only as advanced technology but also as a tool for addressing repetitive workloads, staff shortages, and operational efficiency.

Mobile delivery robots are expected to remain an important area of market development as hospitals expand automated transportation of medications, laboratory samples, and supplies. At the same time, wearable exoskeletons and rehabilitation robots are expected to benefit from improving clinical evidence and reimbursement pathways.

Long-term care is also expected to become an increasingly important opportunity as populations age and healthcare systems search for technologies that can support caregivers. Government subsidies and public-private healthcare automation programs could further accelerate adoption in countries facing significant shortages of care workers.

Advances in artificial intelligence, autonomous navigation, computer vision, human-robot interaction, and onboard computing are expected to improve the capabilities of nursing robots during the forecast period. As more robots operate in real-world healthcare environments, deployment data is expected to contribute to improvements in navigation, task planning, safety, and interaction with healthcare workers.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/nursing-robot-market

The Nursing Robot Market report provides detailed analysis of market size, revenue forecasts, segmentation, competitive positioning, regional trends, growth drivers, restraints, regulatory developments, and emerging opportunities across the global healthcare robotics industry.

About Emergen Research

Emergen Research is a market research and consulting company providing syndicated research reports, customized research solutions, and strategic consulting services across a wide range of industries. The company's research covers emerging technologies, healthcare, pharmaceuticals, chemicals and materials, information technology, energy, manufacturing, and other rapidly developing sectors.

Emergen Research's research solutions are designed to support businesses, investors, researchers, and strategic decision-makers with market intelligence, industry analysis, competitive assessments, and future growth insights.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: [email protected]